Study of Cabazitaxel in Patients With Metastatic Breast Cancer Previously Treated With Taxanes

PHASE2CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

July 10, 2017

Study Completion Date

July 20, 2017

Conditions
Breast Cancer
Interventions
DRUG

Cabazitaxel

Trial Locations (17)

11525

Dept of Medical Oncology, 251 General Air Force Hospital, Athens

11527

"2nd Dept of Medical Oncology, General Hospital of Athens Hippokratio", Athens

11528

"Oncology section, Dept of Clinical Therapeutics, General Hospital of Athens Alexandra", Athens

12462

"Division of Oncology, 2nd Dept of Internal Medicine, Propaedeutic, University Hospital Attikon", Athens

14564

2nd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens

3rd Dept of Medical Oncology, Agii Anargiri Cancer Hospital, Athens

15123

3rd Dept of Medical Oncology, Hygeia Hospital, Athens

18547

1st Dept of Medical Oncology, Metropolitan Hospital, Athens

2nd Dept of Medical Oncology, Metropolitan Hospital, Athens

26335

"General Hospital of Patra Agios Andreas", Pátrai

26504

Division of Oncology, Dept of Internal Medicine, University Hospital of Patras, Rio, Patras

45110

Dept of Medical Oncology, Ioannina University Hospital, Ioannina

56429

Dept of Medical Oncology, Papageorgiou General Hospital, Thessaloniki

57001

Dept of Medical Oncology, Thermi Clinic S.A, Thessaloniki

71110

Dept of Medical Oncology, University Hospital of Heraklion, Heraklio

73300

"Oncology Dept., General Hospital of Chania Agios Georgios", Chania

Unknown

2nd Dept of Medical Oncology, Agios Savvas Cancer Hospital, Athens

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Sanofi

INDUSTRY

lead

Hellenic Cooperative Oncology Group

OTHER